Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,773.15 -822.94 (-1.27%) CMC Crypto 200
1,329.17 -67.36 (-4.82%)
The fight against COVID19
23.81k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The fight against COVID19 | +0.19% | - | - | - |
| ^GSPC | +1.02% | -2.83% | +23.33% | +5383.83% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 146.14 | -0.68 | -0.46% | 4:00 pm GMT-4 | 6.13M | 7.66M | 352.17B |
| ABBV | AbbVie Inc. | 159.62 | -7.67 | -4.58% | 4:00 pm GMT-4 | 10.63M | 5.63M | 282.63B |
| PFE | Pfizer Inc. | 25.4 | +0.14 | +0.55% | 4:01 pm GMT-4 | 46.01M | 42.22M | 143.83B |
| SNY | Sanofi | 49.13 | -0.23 | -0.47% | 4:00 pm GMT-4 | 4.14M | 2.02M | 122.65B |
| REGN | Regeneron Pharmaceuticals, Inc. | 883.2 | -7.48 | -0.84% | 4:00 pm GMT-4 | 502.94k | 466.46k | 96.94B |
| GSK | GSK plc | 41.11 | +0.20 | +0.49% | 4:00 pm GMT-4 | 2.55M | 3.49M | 83.99B |
| GILD | Gilead Sciences, Inc. | 65.42 | +0.15 | +0.23% | 4:00 pm GMT-4 | 12.35M | 7.35M | 81.58B |
| MRNA | Moderna, Inc. | 107.97 | +1.79 | +1.69% | 4:00 pm GMT-4 | 2.24M | 3.78M | 41.34B |
| TAK | Takeda Pharmaceutical Company Limited | 13.03 | -0.04 | -0.31% | 4:00 pm GMT-4 | 1.21M | 1.84M | 41.20B |
| BNTX | BioNTech SE | 87.21 | +0.50 | +0.58% | 4:00 pm GMT-4 | 348.30k | 593.18k | 21.02B |
| VIR | Vir Biotechnology, Inc. | 8.23 | +0.60 | +7.86% | 4:00 pm GMT-4 | 1.09M | 1.05M | 1.12B |
| NVAX | Novavax, Inc. | 4.09 | +0.14 | +3.54% | 4:00 pm GMT-4 | 3.01M | 7.19M | 572.41M |
| INO | Inovio Pharmaceuticals, Inc. | 10.57 | +0.44 | +4.40% | 4:00 pm GMT-4 | 193.22k | 479.70k | 273.83M |
- Yahoo Finance Video
Abbvie stock falls amid growing biosimilar competition
Pharmaceutical giant AbbVie Inc. (ABBV) shares came under pressure as the market closed on Friday, following the disappointing first quarter sales performance of the company's arthritis drug, Humira. The company forecast that Humira's sales could slow further in the face of heightened competition. Yahoo Finance's health reporter Anjalee Khemlani breaks down the details, providing insight into the rise of biosimilars in the market. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance. This post was written by Angel Smith
Investor's Business DailyA Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed
Stock market investors brace for a big week of earnings and econ as Apple, Amazon, Big Pharma and The Fed all line up to deliver news.
BenzingaFDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Friday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate to severe hemophilia B in adult patients who currently use factor IX (FIX) prophylaxis therapy or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes, and do not have neutralizing antibodies to adeno-associated virus serotype Rh74var capsid. Beqvez is a one-time treatment designed to enable hemophilia B patients to produce FIX themselves
